title: Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy.
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia 19104.
authors.forename: D
authors.initials: D
authors.lastname: Glover
authors.forename: K R
authors.initials: KR
authors.lastname: Fox
authors.forename: C
authors.initials: C
authors.lastname: Weiler
authors.forename: M M
authors.initials: MM
authors.lastname: Kligerman
authors.forename: A
authors.initials: A
authors.lastname: Turrisi
authors.forename: J H
authors.initials: JH
authors.lastname: Glick
mesh_terms: D000477:Alkylating Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D004999:Amifostine / Q000627:therapeutic use*; D002945:Cisplatin / Q000037:antagonists & inhibitors; D003520:Cyclophosphamide / Q000037:antagonists & inhibitors; D004341:Drug Evaluation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000517:prevention & control
chemical_list: D000477:Alkylating Agents; D009946:Organothiophosphorus Compounds; D003520:Cyclophosphamide; D004999:Amifostine; D002945:Cisplatin